Monsanto Growth Ventures

Monsanto Growth Ventures

Helping teams to develop inspiring agriculture products

Corporate | United States of America | Income/Productivity Growth

 

Overview

Monsanto Growth Ventures (MGV) is the venture capital arm of the Monsanto Company. The MGV investment professionals invest in emerging teams and ideas that improve agriculture across technologies and geographies. As a result the MGV portfolio consists of companies spanning a diverse spectrum. This ranges from biotechnology to pharmaceuticals and microbes to software marketplaces and connected devices. MGV strives to help talented teams develop inspiring products for agriculture and related industries across the globe.

Investor Type

Legal Structure

Operating Status

Members

Corporate C Corporation Operating 5

Portfolio

Mar, 2017

 $6,5M Series A

FarmLead

Facilitating greater efficiency in grain marketing

FarmLead is a digital marketplace that allows buyers and sellers...

sector

Income/Productivity Growth
Food Security
Access to Information

regions

United States of America
Canada

People

Brennan Turner

Dec, 2015

Joint Series B Equity PRI

AgBiome  

Crop Microbiome Biotech Company.

AgBiome is redefining agriculture. They are an early stage provider...

sector

Agricultural Productivity

regions

United States of America

People

Eric Ward

Dec, 2012

 $2M Seed Equity Other

AgBiome  

Crop Microbiome Biotech Company.

AgBiome is redefining agriculture. They are an early stage provider...

sector

Agricultural Productivity

regions

United States of America

People

Eric Ward

Load More

Investors / Funders


Team


Funds


Impact

Social Objectives:

Environmental Objectives:


Operational Impact:


Impact Reports & Metrics


Offices

Monsanto Headquarters :

800 N. Lindbergh Boulevard
St. Louis Montana 63167
United States of America



Explore

Revision History

Last Update: Aug 07, 2017 1:19 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Twitter

Tags

COPYRIGHT 2024 IMPACTSPACE. ALL RIGHTS RESERVED.